Ligand Pharma (LGND) Tops Q1 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. INSP
9. DOX
10. SPY

Go back to Ligand Pharma (LGND) Tops Q1 EPS by 30c

Ligand Reports First Quarter 2016 Financial Results

May 4, 2016 6:01 AM EDT

Management to discuss the quarter during an investment conference presentation beginning at 1:30 p.m. Eastern time today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2016, and provided an operating forecast and program updates.

Financial highlights for the first quarter of 2016 include:

First quarter total revenues were $29.6 million, including royalty revenues of $14.4 million. First quarter adjusted EPS was $0.97 and GAAP EPS was $0.30.

A description of adjusted calculations and reconciliation... More